Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Anthem Inc    ANTM

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

Anthem : Says ACA Payment Loss Could Cause 20% Premium Hike -- Update

share with twitter share with LinkedIn share with facebook
share via e-mail
04/26/2017 | 09:05pm CET
By Anna Wilde Mathews and Austen Hufford 

Anthem Inc. said the loss of key federal payments that support Affordable Care Act plans could push premiums up 20% or more and lead it to pull back from the business, raising the stakes on the issue as House Speaker Paul Ryan said the money wasn't going to be included in an April spending bill.

The remarks by Mr. Ryan left the fate of the payments increasingly murky at a time when Anthem and other insurers are struggling to make decisions about their 2018 ACA plans. Speaking to analysts early Wednesday before Mr. Ryan's comments, Anthem said it would make initial rate filings that assume the continuation of the federal payments, which are provided to help low-income enrollees with health costs. But if the cost-sharing funding isn't guaranteed by early June, Anthem will need to make changes that could include further raising rates and cutting back in, or completely exiting, certain markets, said Joseph R. Swedish, the insurer's chief executive.

He said Anthem will continue to offer ACA plans only in markets that are on a "visible path toward sustainability," and currently "some markets are expected to be operating on a sustainable basis."

Mr. Swedish also said Anthem "has not ruled anyone in or out" in its effort to craft a new pharmacy-benefit management deal, appearing to cut against remarks by the insurer's current PBM, Express Scripts Holdings Inc. Express Scripts saw its shares drop sharply after it disclosed late Monday that it believes Anthem doesn't intend to renew its 10-year contract when it expires at the end of 2019. The two companies are dueling in court over their existing deal.

Mr. Swedish said the insurer still believes it should receive $3 billion more in savings each year on its PBM arrangement "at a minimum," and he said repeatedly that Anthem is still considering all possible pharmacy-benefit vendors for 2020 and beyond.

A spokesman for Express Scripts said Anthem officials "haven't wanted to talk about a contract extension."

Express Scripts Chief Executive Tim Wentworth told The Wall Street Journal in an interview that an Anthem executive called him about two weeks ago and said that Anthem's "executive team here has concluded 'we're going to go in another direction. I know it's probably surprising to you,'" said Mr. Wentworth. "And it was [surprising]."

Anthem's comments about the ACA plans and its pharmacy-benefit situation came as the insurer reported a first-quarter profit of $1.01 billion, or $3.73 a share, up from $703 million, or $2.63 a share, a year earlier. On an adjusted basis, earnings per share were $4.68. Revenue climbed 11% to $22.53 billion, and operating revenue rose 9.9% to $22.32 billion. Revenue growth was led by premium increases and by rising enrollment in segments including Medicaid and Medicare. Analysts surveyed by Thomson Reuters had forecast per-share earnings of $3.86 on operating revenue of $21.27 billion.

Mr. Swedish also said his company remains committed to its deal to acquire Cigna Corp. Anthem is appealing a court's antitrust ruling blocking the combination, but Cigna has said it wants out of the deal. Anthem and Cigna are currently suing one another, the culmination of months of tension between the merger partners.

Anthem's position on the ACA marketplaces is being closely watched because of its reach -- it is a major presence in 14 state exchanges, with nearly 1.6 million people enrolled in its ACA plans, 1.1 million of those bought through the marketplaces. Currently, 302 counties in states including Georgia, Missouri and Ohio have only Anthem plans available on their marketplaces, according to the Kaiser Family Foundation.

Around the country, exchange insurers have said they are finding it difficult to plot their 2018 strategy amid the uncertainty about the future of the ACA. House Republicans are now trying to move ahead with a revamped version of a major health overhaul.

Mr. Ryan's comments Wednesday about this month's spending bill -- in which he said of the ACA cost-sharing payments, "we're not doing that"--threw cold water on insurance-industry hopes that the federal money would soon be locked in by Congress.

Anthem's Mr. Swedish said that in addition to the potential rate increases tied to the loss of the cost-sharing payments, ACA-plan premiums are likely to be pushed up 4% to 5% next year based on the return of an insurer tax included in the ACA, which was suspended for 2017.

Anthem said that so far, claims costs for its ACA enrollees are running slightly higher than it had predicted this year, but the results are better than what Anthem saw at this point last year. The insurer said it is still expecting to be break-even or slightly better on its individual business in 2017.

Joseph Walker contributed to this article.

Write to Anna Wilde Mathews at [email protected] and Austen Hufford at [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ANTHEM INC
12/11 ANTHEM : NFL's Players Coalition compact is a misguided effort
12/07 ANTHEM, INC. : Change in Directors or Principal Officers, Regulation FD Disclosu..
12/07 ANTHEM : Board Welcomes Antonio Neri as New Director
12/06 ANTHEM : Blue Cross Blue Shield Policy in Indiana -- Violates Federal Law, Puts ..
12/05 Value-based models a driver of CVS-Aetna deal
12/05 CVS, Aetna executives defend $69 billion deal to skeptical Wall Street
12/05 CVS, Aetna executives defend $69 billion deal to skeptical Wall Street
12/05 CVS, Aetna executives defend $69 billion deal to sceptical Wall Street
12/04 A.M. BEST : Assigns Indicative Issue Credit Ratings to Anthem, Inc.’s New ..
12/04 CVS says deal to help build Anthem's drug benefit still on
More news
News from SeekingAlpha
12/12 The Only Good Three Ideas From Barron's
12/09 Stocks to watch next week
12/07 Anthem boosts share buybacks by $5B
12/04 My Dividend Growth Portfolio Update - 48 Holdings, 1 Buy
12/01 Healthcare events next week
Financials ($)
Sales 2017 88 724 M
EBIT 2017 4 608 M
Net income 2017 2 830 M
Debt 2017 -
Yield 2017 1,18%
P/E ratio 2017 20,84
P/E ratio 2018 18,34
Capi. / Sales 2017 0,66x
Capi. / Sales 2018 0,64x
Capitalization 58 315 M
Duration : Period :
Anthem Inc Technical Analysis Chart | ANTM | US0367521038 | 4-Traders
Technical analysis trends ANTHEM INC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 232 $
Spread / Average Target 1,9%
EPS Revisions
Gail Koziara Boudreaux President, Chief Executive Officer & Director
Joseph R. Swedish Chairman
John E. Gallina Chief Financial Officer & Executive Vice President
Craig E. Samitt Chief Clinical Officer & Executive Vice President
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ANTHEM INC61.41%58 315
AETNA INC44.43%58 206
HUMANA INC25.59%35 802
CENTENE CORP79.07%17 088